Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
(DISCOVERY Trial)
Recruiting in Palo Alto (17 mi)
+29 other locations
Overseen ByNatalia Rost, MD, MPH
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Massachusetts General Hospital
No Placebo Group
Trial Summary
What is the purpose of this trial?The overall goal of the DISCOVERY study is to better understand what factors contribute to changes in cognitive (i.e., thinking and memory) abilities in patients who experienced a stroke. The purpose of the study is to help doctors identify patients at risk for dementia (decline in memory, thinking and other mental abilities that significantly affects daily functioning) after their stroke so that future treatments may be developed to improve outcomes in stroke patients. For this study, a "stroke" is defined as either (1) an acute ischemic stroke (AIS, or blood clot in the brain), (2) an intracerebral hemorrhage (ICH, or bleeding in the brain), (3) or an aneurysmal subarachnoid hemorrhage (aSAH, or bleeding around the brain caused by an abnormal bulge in a blood vessel that bursts).
The investigators hypothesize that:
1. The size, type and location of the stroke play an important role in recovery of thinking and memory abilities after stroke, and pre-existing indicators of brain health further determine the extent of this recovery.
2. Specific stroke events occurring in individuals with underlying genetic or biological risk factors can cause further declines in brain heath, leading to changes in thinking and memory abilities after stroke.
3. Studying thinking and memory alongside brain imaging and blood samples in patients who have had a stroke allows for earlier identification of declining brain health and development of individualized treatment plans to improve patient outcomes in the future.
Eligibility Criteria
Inclusion Criteria
Age ≥18 years
Admitted to the hospital with a diagnosis of acute ischemic stroke (AIS), intracerebral hemorrhage (ICH), or aneurysmal subarachnoid hemorrhage (aSAH)
Radiographic confirmatory evidence of: (1) AIS (based on a focal area of restricted diffusion on MRI), (2) non-traumatic ICH (based on evidence of acute parenchymal hemorrhage CT or brain MRI) or (3) non-traumatic acute aSAH (based on evidence of subarachnoid hemorrhage on CT or MRI and evidence of aneurysm on CT angiography, MR angiography, or conventional catheter-based angiography)
+3 more
Participant Groups
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Barrow Neurological InstitutePhoenix, AZ
Kaiser Permanente Los Angeles Medical CenterLos Angeles, CA
Cedars Sinai Medical CenterLos Angeles, CA
University of California Los AngelesLos Angeles, CA
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Massachusetts General HospitalLead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)Collaborator